Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence 
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake 
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline 
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits 
CXMT IPO Debut in Shanghai Puts $85.5 Billion Chipmaker in Spotlight 
Tech Stock Positioning Nears Neutral as Investor Rotation Enters Final Phase, Deutsche Bank Says 
Nvidia Invests $1 Billion in Naver as South Korea AI Data Center Expansion Gains Momentum 
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors 
Air Liquide Q2 Sales Growth Tops Forecast as Electronics Business Drives Strong Performance 
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook 
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers 
Serica Energy to Acquire Pharos Energy for £145.7M, Sending PHARP Shares Soaring 
Barclays Q2 Profit Beats Forecasts as Investment Banking Strength Offsets Higher Costs 
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation 
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline 
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth 
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook 
Top South Korean cosmetics maker Amorepacific Corp. suffered a net loss of 58.9 billion won in the fourth quarter, increasing 1.7 percent from the 57.9 billion won a year ago, mainly due to the pandemic's impact.
According to the firm, it endured a decrease in offline and duty-free sales with the spread of COVID-19 limiting local shopping and reducing the number of inbound tourists.
However, online sales soared by about 50 percent.
The company also posted a 9.2 million won operating loss in the quarter, after enjoying a 45.9 billion won operating profit during the same period a year before. Sales plunged 13.3 percent to 1.16 trillion won during the said period.
For 2020, Amorepacific Corp. recorded a net profit of 21.9 billion won, down 90.2 percent from 2019. Operating income plunged 66.6 percent on-year to 143 billion won, as sales dropped 20.6 percent to 4.43 trillion won.
The Amorepacific Group, which includes Innisfree and Etude, logged a net income of 22 billion, down 92.2 percent from the previous year. The group's operating profit also slumped 69.8 percent on-year to 150.7 billion won, and sales plummeted 21.5 percent to 4.93 trillion won.
